Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("trial simulation")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Population Pharmacokinetic Model of the Pregabalin-Sildenafil Interaction in Rats: Application of Simulation to Preclinical PK-PD Study DesignBENDER, Gregor; GOSSET, James; FLORIAN, Jeff et al.Pharmaceutical research. 2009, Vol 26, Num 10, pp 2259-2269, issn 0724-8741, 11 p.Article

Simulation of correlated continuous and categorical variables using a single multivariate distributionTANNENBAUM, Stacey J; HOLFORD, Nicholas H. G; LEE, Howard et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 6, pp 773-794, issn 1567-567X, 22 p.Article

Survival distributions impact the power of randomized placebo-phase design and parallel groups randomized clinical trialsABRAHAMYANA, Lusine; SILVIA LIA, Chuan; BEYENEA, Joseph et al.Journal of clinical epidemiology. 2011, Vol 64, Num 3, pp 286-292, issn 0895-4356, 7 p.Article

Randomized exposure-controlled trials; impact of randomization and analysis strategiesKARLSSON, Kristin E; GRAHNEN, Anders; KARLSSON, Mats O et al.British journal of clinical pharmacology. 2007, Vol 64, Num 3, pp 266-277, issn 0306-5251, 12 p.Article

Effect of uncertainty about population parameters on pharmacodynamics-based prediction of clinical trial powerKRAICZI, Holger; FRISEN, Marianne.Contemporary clinical trials. 2005, Vol 26, Num 2, pp 118-130, issn 1551-7144, 13 p.Article

Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug-drug interaction studiesSHUYING YANG; BEERAHEE, Misba.European journal of clinical pharmacology. 2011, Vol 67, Num 3, pp 225-233, issn 0031-6970, 9 p.Article

Population pharmacokinetics of APOMINE: A meta-analysis in cancer patients and healthy malesBONATE, Peter L; FLORET, Simon; BENTZEN, Craig et al.British journal of clinical pharmacology. 2004, Vol 58, Num 2, pp 142-155, issn 0306-5251, 14 p.Article

The use of clinical trial simulation to support dose selection: Application to development of a new treatment for chronic neuropathic painLOCKWOOD, Peter A; COOK, Jack A; EWY, Wayne E et al.Pharmaceutical research. 2003, Vol 20, Num 11, pp 1752-1759, issn 0724-8741, 8 p.Article

Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; An example in Alzheimer's diseaseLOCKWOOD, Peter; EWY, Wayne; HERMANN, David et al.Pharmaceutical research. 2006, Vol 23, Num 9, pp 2050-2059, issn 0724-8741, 10 p.Article

Challenges in implementing adaptive designs : Comments on the viewpoints expressed by regulatory statisticiansGALLO, Paul; MAURER, Willi.Biometrical journal. 2006, Vol 48, Num 4, pp 591-597, issn 0323-3847, 7 p.Article

FDA's critical path initiative : A perspective on contributions of biostatisticsO'NEILL, R. T.Biometrical journal. 2006, Vol 48, Num 4, pp 559-564, issn 0323-3847, 6 p.Article

A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trialsHALL, David B; MEIER, Ulrich; DIENER, Hans-Cristoph et al.Contemporary clinical trials. 2005, Vol 26, Num 3, pp 349-364, issn 1551-7144, 16 p.Article

Pharmacokinetic/pharmacodynamic models for the depletion of vβ5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACSZINGMARK, Per-Henrik; EDENIUS, Charlotte; KARLSSON, Mats O et al.British journal of clinical pharmacology. 2004, Vol 58, Num 4, pp 378-389, issn 0306-5251, 12 p.Article

Topical Microbicides to Prevent HIV : Clinical Drug Development ChallengesHENDRIX, Craig W; YING JUN CAO; FUCHS, Edward J et al.Annual review of pharmacology and toxicology (Print). 2009, Vol 49, pp 349-375, issn 0362-1642, 27 p.Article

Design of Long-Term HIV Dynamic Studies Using Semiparametric Mixed-Effects ModelsYANGXIN HUANG; PARK, Jeong-Gun; YILIANG ZHU et al.Biometrical journal. 2008, Vol 50, Num 4, pp 528-540, issn 0323-3847, 13 p.Article

Opening the adaptive toolboxWITTES, Janet; LACHENBRUCH, Peter A.Biometrical journal. 2006, Vol 48, Num 4, pp 598-603, issn 0323-3847, 6 p.Article

Bayesian experimental design for long-term longitudinal HIV dynamic studiesYANGXIN HUANG; HULIN WU.Journal of statistical planning and inference. 2008, Vol 138, Num 1, pp 105-113, issn 0378-3758, 9 p.Conference Paper

Adaptive designs from the viewpoint of an academic biostatisticianSCHÄFER, Helmut.Biometrical journal. 2006, Vol 48, Num 4, pp 586-590, issn 0323-3847, 5 p.Article

  • Page / 1